Skip to content

Low-dose haloperidol on the quality of postoperative recovery in gynecologic surgery patients

Low-dose haloperidol on the quality of postoperative recovery in gynecologic surgery patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078893
Enrollment
Unknown
Registered
2023-12-20
Start date
2023-12-20
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological diseases (uterus, fibroids, ovaries, tubectomy, etc.)

Interventions

Haloperidol group:Thirty minutes before the end of surgery, the 1.25 mg of haloperidol was diluted to 5 ml with saline and injected slowly intravenously.
Saline group:Thirty minutes before the end of surgery, 5 ml of saline was injected slowly intravenously.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: ? Gynecological patients aged 18-64 years old; ? ASA classification I to III; ? Normal preoperative communication; ? Post-operative ICU admission is not expected; ? Intended to undergo laparoscopic surgery and the duration of surgery > 0.5h; ? Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ?.Severe respiratory and circulatory diseases: e.g. severe coronary heart disease, chronic obstructive pulmonary disease, etc. ?. Allergy to haloperidol. ?.Patients with QTc>500ms on ECG. ?.Severe endocrine system diseases: pituitary tumor, severe diabetes mellitus, etc. ?.Psychiatric disorders: schizophrenia, depression, epilepsy, history of chronic analgesic drugs, alcoholism, opioid dependents, etc. ?.Those who cannot cooperate with the study for any reason: hearing or visual impairment, language comprehension disorders, and those who cannot understand the contents of the QOR-15 scale. ?.Parkinson's disease, history of cerebral infarction, Alzheimer's disease, insomnia, severe hepatic insufficiency (ChildC), renal insufficiency (preoperative dialysis). pre-dialysis) ?. Preoperative life can not take care of themselves. ?. Inability to use intravenous analgesic pump after surgery.

Design outcomes

Primary

MeasureTime frame
QoR-15 score at 24 hours postoperatively.;

Secondary

MeasureTime frame
Wake-up time in the PACU;Post-operative RASS score;Length of stay at PACU;NRS scores at 6h, 12h, 24h and 48h after surgery.;QoR-15 scores on postoperative days 3 and 5.;Sleep scores (AIS) and PONV for the period of the first 3 postoperative days.;The use of opioids and remedial antiemetic drugs;Total length of hospital stay;

Countries

China

Contacts

Public ContactXuesheng Liu

The First Affiliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 193 5658 6436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026